<DOC>
	<DOCNO>NCT02545101</DOCNO>
	<brief_summary>This retrospective chart review non-interventional study design collect real world data use outcomes tolvaptan treatment patient hyponatraemia secondary syndrome inappropriate antidiuretic hormone ( SIADH ) secretion .</brief_summary>
	<brief_title>An Observational Study Real-world Use Outcomes Patients Treated With Tolvaptan Hyponatraemia Due SIADH</brief_title>
	<detailed_description />
	<mesh_term>Hyponatremia</mesh_term>
	<mesh_term>Inappropriate ADH Syndrome</mesh_term>
	<mesh_term>Tolvaptan</mesh_term>
	<criteria>Provision patient inform consent unless ) require local regulation , b ) would take non reasonable effort c ) source patient decease untraceable . Female and/or male patient age 18 year . Patients receive least 2 dos tolvaptan , treatment one occurrence hyponatraemia secondary SIADH . A patient take part study participate clinical study medicinal product aim treat cause symptom hyponatraemia time hyponatraemia episode document current study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Hyponatremia due SIADH</keyword>
	<keyword>tolvaptan</keyword>
</DOC>